Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

A Phase II Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy

Study ID: NCT06569368
Start Date: 2024-07-10
End Date: 2026-10-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Metronidazole

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

Study ID: NCT03721068
Start Date: 2019-02-19
End Date: 2039-06-19
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

iC9.GD2.CAR.IL-15 T-cells

Cyclophosphamide

Fludarabine

Sponsor

UNC Lineberger Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple Myeloma

Study ID: NCT04680468
Start Date: 2021-06-02
End Date: 2026-07-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

47

Intervention / Treatment

Mafodotin Belantamab

Sponsor

University of Pennsylvania

Source: clinicaltrials.gov

Share:
Add to list

Collection of Outcomes Data for Pregnant Patients With Cancer

Study ID: NCT00507572
Start Date: 2005-12-19
End Date: 2025-04-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment

Medical Chart Review

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

Study ID: NCT05649072
Start Date: 2022-11-18
End Date: 2027-02-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

Genetic Testing and Counseling

Screening Form

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant

Study ID: NCT06687772
Start Date: 2025-01-16
End Date: 2029-07-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

36

Intervention / Treatment

Thiotepa

Carmustine

Autologous Stem Cell Transplant

Anthracycline-based induction chemotherapy

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

MRI in High-Grade Glioma Patients Undergoing Chemoradiation

Study ID: NCT05212272
Start Date: 2022-09-02
End Date: 2025-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

16

Intervention / Treatment

PET-MRI Brain Scan

Blood draw

Memory testing

Optional lumbar puncture for cerebrospinal fluid collection

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

Study ID: NCT04165772
Start Date: 2019-12-11
End Date: 2026-11-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

200

Intervention / Treatment

TSR-042 or Dostarlimab

capecitabine or 5-FU

Intensity Modulated Radiation Therapy (IMRT)

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Study ID: NCT06239272
Start Date: 2024-03-27
End Date: 2037-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

139

Intervention / Treatment

Surgical resection

Proton beam radiation therapy

On the feopanib

Ifosfamide

Doxorubicin

Selinexor

Sponsor

St. Jude Children's Research Hospital

Source: clinicaltrials.gov

Share:
Add to list

Accelerated Pulmonary Rehabilitation in the Preoperative Period

Study ID: NCT06432972
Start Date: 2024-01-02
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Pulmonary Rehab

Sponsor

University of Vermont

Source: clinicaltrials.gov

Share:
Add to list